<table border="1" id="id_ce8ae23f-fda3-4610-8781-a12a00db9493" width="0.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_0047aa8a-38b3-470c-abcc-78c2f5674842">Table 3. Percentage of Ulcers Recurring by 3, 6, and 12 Months in Double-Blind Studies Conducted in the United States</caption>
<col></col>
<col></col>
<col></col>
<tbody>
<tr id="id_d2739d99-4e83-467d-bad3-ef7170c7ce58">
<td align="left" stylecode="Toprule Rrule" valign="top">
<content stylecode="underline">Month</content>
</td>
<td align="left" stylecode="Rrule" valign="top">
<content stylecode="underline">Nizatidine, 150 mg h.s.</content>
</td>
<td align="left" valign="top">
<content stylecode="underline">Placebo</content>
</td>
</tr>
<tr id="id_ea91541b-c05f-48ec-9b7a-ba3e19977e1d">
<td align="left" stylecode="Rrule" valign="top">3</td>
<td align="left" stylecode="Rrule" valign="top">13% (28/208)<footnote id="id-387df621-162c-4bfa-bc4c-0dfe9dac3ae1">
<content stylecode="italics">P</content> &lt;0.001 as compared with placebo</footnote>
</td>
<td align="left" valign="top">40% (82/204)</td>
</tr>
<tr id="id_d7722449-003f-4fe2-8bc2-25f62cee664e">
<td align="left" stylecode="Rrule" valign="top">6</td>
<td align="left" stylecode="Rrule" valign="top">24% (45/188)<footnoteref idref="id-387df621-162c-4bfa-bc4c-0dfe9dac3ae1"></footnoteref>
</td>
<td align="left" valign="top">57% (106/187)</td>
</tr>
<tr id="id_fe010982-9451-459b-8485-4ee4da23478e">
<td align="left" stylecode="Botrule Rrule" valign="top">12</td>
<td align="left" stylecode="Rrule" valign="top">34% (57/166)<footnoteref idref="id-387df621-162c-4bfa-bc4c-0dfe9dac3ae1"></footnoteref>
</td>
<td align="left" stylecode="Botrule" valign="top">64% (112/175)</td>
</tr>
</tbody>
</table>